Switching to Impella 5.0 decreases need for transfusion in patients undergoing temporary mechanical circulatory support

Various options of temporary mechanical circulatory support (tMCS) exist for the treatment of cardiogenic shock, however, all forms of tMCS carry a risk of complications. The aim of this study was to compare bleeding complications and thromboembolic events under extracorporeal life support + Impella 2.5/CP (ECMELLA) and isolated Impella 5.0 therapy in the same patient cohort. We retrospectively analyzed data of patients who underwent ECMELLA...